Dosage and administration
For intravenous administration only. Cattle 250-500 mL Dosage may be repeated at 8 to 12 hour intervals if required.
For intravenous administration only. Cattle 250-500 mL Dosage may be repeated at 8 to 12 hour intervals if required.
Store between 15 degrees C - 30 degrees C (59 degrees F - 86 degrees F).
KEEP OUT OF REACH OF CHILDREN
For use in cattle as an aid in treating uncomplicated milk fever (parturient paresis).
For intravenous administration only.
Cattle 250-500 mL
Dosage may be repeated at 8 to 12 hour intervals if required.
Solution should be warmed to body temperature and administered slowly. Entire contents should be used upon entering, as this product contains no preservative. Discard any unused portion. Do not use if solution is cloudy or contains precipitate.
Monitor animal's condition closely. Re-treatment may be necessary. If there is no noticeable improvement within 24 hours following treatment, consult your veterinarian. Aseptic precautions should be observed.
RMS 92-545 Iss. 04-11
18-802-50
Manufactured For
VETTEK
Blue Springs, MO 64014
NET CONTENTS: 500 mL
Lot No. Exp.
STERILE
For Animal Use Only
ACTIVE INGREDIENTS:
Calcium Gluconate
(provides 2.14 grams
Calcium............................23 grams
Water for Injection..........................q.s.
Boric Acid (as a solubilizing agent)..................................3.5 grams
Electrolytes per 1000 mL:
Calcium 1069 mEq;
Hypertonic pH 2.5-4.5
Osmolarity (calc.)
6,782 mOsmol/L
Store between 15 degrees C - 30 degrees C (59 degrees F - 86 degrees F).
TAKE TIME OBSERVE LABEL DIRECTIONS
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0745801102507 | GTIN-13: 0745801102507 EAN-13: 0745801102507 GTIN-12: 745801102507 UPC-A: 745801102507 GTIN storage (14 digits): 00745801102507 | 92-545.jpg |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM GLUCONATE | ACTIVE INGREDIENT | SQE6VB453K | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| BORIC ACID | INACTIVE INGREDIENT | R57ZHV85D4 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60270-852 | 60270-852-17 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM GLUCONATE | SQE6VB453K | ACTIB |
| BORIC ACID | R57ZHV85D4 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION / AURICULAR (OTIC) | 0.05 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION/ DROPS / OPHTHALMIC | 48 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | EMULSION / TOPICAL | 1.3 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | MOUTHWASH / BUCCAL | 7.36 mg/1ml | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SHAMPOO / TOPICAL | 2 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | JELLY / VAGINAL | 1 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.3 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 0.53 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / OPHTHALMIC | 22 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION / AURICULAR (OTIC) | 0.6 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SOLUTION / OPHTHALMIC | 60 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / TOPICAL | 0.3 %w/v | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | INJECTION, SOLUTION / INTRAVENOUS | 210 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | GEL / OPHTHALMIC | 0.5 %w/w | ||
| BORIC ACID | BORIC ACID | R57ZHV85D4 | DROPS / OPHTHALMIC | 1 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| calcium gluconate | CALCIUM GLUCONATE | REMEDYREPACK INC. | d6db3a1c-ed02-48fc-9134-ea1d58acf42e | 2026-09-08 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| calcium gluconate | CALCIUM GLUCONATE | Amneal Pharmaceuticals Private Limited | 787603c6-3f50-473a-8e3b-71dcf6d86964 | 2026-06-23 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | GLENMARK PHARMACEUTICALS INC., USA | b2470072-f443-4596-ae33-1b8b0d05bc9d | 2026-06-11 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | Fresenius Kabi USA, LLC | 8b77c3d2-992d-4261-8421-9cfd07328fbf | 2026-05-18 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | Caplin Steriles Limited | f28e9871-d546-4b48-ac3d-aead0d4c0449 | 2026-05-13 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| calcium gluconate | CALCIUM GLUCONATE | Amneal Pharmaceuticals Private Limited | 13d7cfc9-ff7a-437e-8c21-d9709ac07d48 | 2026-05-12 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | Henry Schein, Inc. | 3cbf6bf7-2415-4435-b3df-41855514a05d | 2025-12-23 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | Henry Schein, Inc. | 841ea51f-dc0d-45ed-8b55-bb64640cb930 | 2025-11-03 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | REMEDYREPACK INC. | 4c635f60-7868-46d5-b932-d5cf8fc84432 | 2025-09-29 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | ProPharma Distribution | 38413366-b558-7dd0-e063-6394a90acb7e | 2025-07-18 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE | Somerset Therapeutics, LLC | fb40eba7-04e5-40dc-8a95-5f45e7bd70bc | 2025-02-06 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | Fresenius Kabi USA, LLC | 1aaf5c76-e526-4d8b-887e-cc3c4f39cc8b | 2024-08-21 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | Fresenius Kabi USA, LLC | 7f5101e0-abf9-4fcf-8986-c799e3333434 | 2024-05-06 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE | Amneal Pharmaceuticals Private Limited | 8ee79b4c-21d3-4742-ae37-e2f562917706 | 2024-04-18 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE | HF Acquisition Co LLC, DBA HealthFirst | 788ab6d7-d80c-0220-e053-2991aa0ae6e9 | 2024-02-01 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| calcium gluconate | CALCIUM GLUCONATE | Hikma Pharmaceuticals USA Inc. | 8ec4d137-1e9b-40e2-aeb2-8f62626a8fa5 | 2023-09-01 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| calcium gluconate | CALCIUM GLUCONATE | Hikma Pharmaceuticals USA Inc. | ce7becd8-cf59-4470-aac8-82761a24ebd7 | 2023-09-01 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| calcium gluconate | CALCIUM GLUCONATE | Hikma Pharmaceuticals USA Inc. | 313a4ea9-178b-495e-9bc7-af1860fa6501 | 2023-05-26 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | Medical Purchasing Solutions, LLC | b6226367-b061-eec5-e053-2a95a90a617d | 2023-05-04 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
| Calcium Gluconate | CALCIUM GLUCONATE | B. Braun Medical Inc. | af362bcb-7010-4eb5-b8c4-42aa3b0cdcde | 2023-04-28 | Warnings, Adverse reactions | CALCIUM GLUCONATE |
Adverse event summaries are temporarily unavailable. Other product information remains available.